By Super Admin

Seeking Alpha / - 11 hours ago

Celestica Announces TSX Acceptance of Normal Course Issuer Bid

TORONTO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Celestica Inc. (NYSE: CLS) (TSX: CLS), a global leader in data center infrastructure and advanced technology solutions, today announced that the Toronto Stock Exchange (the “TSX”) has accepted the Company's notice to launch a Normal Course Issuer Bid (the...

Seeking Alpha / - 11 hours ago

AdminaHealth Achieves 99% Client Retention and +70 NPS

While new WTW data shows heightened vendor switching due to cost pressures, AdminaHealth earns high marks for stability, ROI, and data security leadership. GREENWICH, Conn., Oct. 30, 2025 /PRNewswire/ -- AdminaHealth®, the leading provider of automated premium billing solutions for the...

Seeking Alpha / - 11 hours ago

Supermicro breidt samenwerking met NVIDIA uit en versterkt compliance, data-integriteit en kwaliteit van in de VS gevestigde productie van AI-infrastructuuroplossingen die voor overheidstoepassingen zijn geoptimaliseerd

Verdere samenwerking met NVIDIA om in 2026 NVIDIA Vera Rubin NVL144 en NVIDIA Vera Rubin CPX platformen op de markt te brengen om meer dan 3x AI-aandachtsversnelling te bieden in vergelijking met Blackwell Ultra Ondersteund door Data Center Building Block Solutions® introduceert...

Seeking Alpha / - 11 hours ago

KRWQ: The First Korean Won Stablecoin on Base

KRWQ launches as the first tradeable Korean Won stablecoin on Base with multi-chain support powered by LayerZero SEOUL, South Korea, Oct. 30, 2025 /PRNewswire/ -- IQ, in partnership with Frax, today announced the launch of KRWQ, the first fiat-backed and multichain stablecoin pegged 1:1...

Seeking Alpha / - 11 hours ago

Unicycive Therapeutics Announces Upcoming Presentation of New Data Reinforcing the Potential of Oxylanthanum Carbonate for the Treatment of Hyperphosphatemia at the American Society of Nephrology Kidney Week 2025 Conference

Analysis of the data from the open-label pivotal trial of oxylanthanum carbonate (OLC) highlights that pill burden was significantly reduced in terms of both pill volume (7x) and pill count (2x) from pre-trial phosphate binder therapy Analysis of the data from the open-label pivotal trial of oxylant...

Seeking Alpha / - 11 hours ago

Cartesian Therapeutics Announces New Employment Inducement Grants

FREDERICK, Md., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced the granting of inducement awards to two new employees. On October 27, 2025, the Co...